Subcutaneous ALXN1830 in Adult Participants With Warm Autoimmune Hemolytic Anemia

Clinical trial NCT04956276 · WITHDRAWN

Trial details

NCT number: NCT04956276
Sponsor: Alexion Pharmaceuticals, Inc.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Warm Autoimmune Hemolytic Anemia

Start date: 2022-01-01
Primary completion: 2022-07-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.